» Articles » PMID: 16490428

Relation of Coronary Collateral Vessel Development in Patients with a Totally Occluded Right Coronary Artery to the Metabolic Syndrome

Overview
Journal Am J Cardiol
Date 2006 Feb 24
PMID 16490428
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Development of coronary collaterals (CCs) is triggered by the gradient between arteries due to obstruction and myocardial ischemia. Presence of CCs that feed the jeopardized myocardial area may limit the infarct size after coronary occlusion and may even provide a survival benefit. However, some patients develop good CCs, whereas others do not. The metabolic syndrome (MS) has been identified as a secondary target to decrease cardiovascular risk, although the effect of MS on development of CCs has not been investigated. We prospectively enrolled 596 consecutive patients (337 men and 259 women; mean age 56 +/- 8 years) who underwent coronary angiography at our center and were found to have total occlusion of the right coronary artery. Patients were then classified as having good CCs (Rentrop's grades 2 to 3) or poor CCs (Rentrop's grades 0 to 1). There were significant differences in terms of body mass index (kilograms of body weight divided by square meters of height), glucose levels, triglyceride levels, and years with angina pectoris between those with good and poor CCs. Prevalences of diabetes mellitus were 27.1% among patients with good CCs and 44% among those with poor CCs (p <0.001). Presence of MS was significantly higher in patients with poor CCs than in those with good CCs (78.4% vs 49.2%, p <0.001). In regression analysis, duration of angina pectoris (beta = 0.347, 95% confidence interval [CI] 0.266 to 0.453, p <0.001), presence of diabetes mellitus (beta = 1.829, 95% CI 1.021 to 3.279, p = 0.042), wall score (beta = 2.379, 95% CI 1.356 to 4.173, p = 0.003), and presence of MS (beta = 2.993, 95% CI 1.541 to 5.813, p = 0.001) were independent predictors of angiographically determined poor CCs. In conclusion, MS seems to be independently associated with poor CCs in patients with an occluded right coronary artery.

Citing Articles

Impact of coronary collateralization on major adverse cardiovascular and cerebrovascular events after successful recanalization of chronic total occlusion.

Sun Y, Zhang B, Zhang X, Zhang X, Bao W, Bai H Front Cardiovasc Med. 2024; 11:1374398.

PMID: 38984350 PMC: 11231425. DOI: 10.3389/fcvm.2024.1374398.


Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Liu T, Wu Z, Liu J, Lv Y, Li W Cardiovasc Diabetol. 2021; 20(1):104.

PMID: 33971883 PMC: 8111979. DOI: 10.1186/s12933-021-01297-4.


Visceral fat index: a novel predictor for coronary collateral circulation.

Sahinturk Y, Kucukseymen S, Avci R, Akarsu A, Oguz Yolcular B, Koker G Arch Endocrinol Metab. 2020; 64(2):150-158.

PMID: 32236316 PMC: 10118954. DOI: 10.20945/2359-3997000000218.


Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single-Domain Llama-Derived Antibody.

Hollander M, Jansen M, Hopman L, Dolk E, van de Ven P, Knaapen P J Am Heart Assoc. 2019; 8(20):e012806.

PMID: 31594443 PMC: 6818022. DOI: 10.1161/JAHA.119.012806.


Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease.

Zettervall S, Marshall A, Fleser P, Guzman R J Vasc Surg. 2017; 67(2):507-513.

PMID: 28870682 PMC: 6085869. DOI: 10.1016/j.jvs.2017.06.086.